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Abstract Five distinct membrane-type matrix metalloprotein-
ases (MT-MMP) have been reported by cDNA cloning.
However, the mt4-mmp gene product (MMP-17) has not been
identified yet in spite of the cDNA isolation [Puente et al. (1996),
Cancer Res. 56, 944^949]. In this study, we re-examined the
transcripts for human mt4-mmp by 5P RACE and identified two
types of transcripts. The minor one corresponded to the cDNA
reported by Puente et al. and failed to express protein, and the
other is the major transcript that has an extended open reading
frame and expressed 67 and 71 kDa translation products. Thus,
functional mt4-mmp has been identified for the first time.
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1. Introduction
Matrix metalloproteinases (MMPs), also called ‘Matrixin’,
are zinc metalloendopeptidases that play critical roles in tissue
formation, maintenance and remodeling of the extracellular
matrix [1^3]. In addition to the soluble-type MMPs, we and
others recently identi¢ed a new subgroup of MMPs, mem-
brane-type MMPs (MT-MMPs), that are anchored to the
plasma membrane through the transmembrane domain
present at the C-terminus [4].
Complementary DNA sequences for ¢ve human MT-
MMPs have been reported [5^9]. MT1, MT2, MT3 and
MT5-MMPs (MMP-14, 15, 16 and 24, respectively) are
closely related to each other in their amino acid sequences
(70^80% homology) and share an activity to induce pro-gelat-
inase A (proMMP-2) activation by introducing a cleavage in
the propeptide [10^14]. On the other hand, MT4-MMP
(MMP-17) reported by Puente et al. [8] is unique compared
to the other four MT-MMPs in that the expected translation
product does not show obvious homology (less than 40%). In
addition, MT4-MMP is di¡erent from all other MMPs in that
it lacks a signal peptide for secretion. The translation product
from the reported cDNA sequence is expected to start from
the middle of the propeptide sequence (Fig. 1A), though the
product has not been detected yet. Thus, there is no informa-
tion about the mechanism of secretion and the biochemical
nature of MT4-MMP.
In this study, we re-examined the transcripts from the hu-
man mt4-mmp (mt4-mmp(h)) gene by the 5P RACE method
and identi¢ed a new major transcript that can encode a gene
product in addition to the one previously identi¢ed by Puente
et al.
2. Materials and methods
2.1. Cells and culture
A human acute monocytic leukemia cell line, THP-1 (ATCC
455303), and a human breast carcinoma cell line, T-47D (ATCC
45528), were cultured in RPMI 1640 supplemented with 10% fetal
calf serum (FCS) under a 5% CO2 atmosphere. For transfection ex-
periments, COS-1 cells were cultured in Dulbecco’s modi¢ed Eagle’s
medium (DMEM) supplemented with 10% FCS. Cells were trans-
fected with plasmids using FuGene 6 (Roche Molecular Biochemicals,
Basel, Switzerland) according to the manufacturer’s instructions.
2.2. Cloning and sequencing
An oligo(dT)-primed cDNA library was constructed from mouse
17-day embryo brain poly(A) RNA using lamdaZAP II (Stratagene)
as a vector. The cDNA library was screened with a 32P-labeled human
mt4-mmp cDNA (233^1899 nt of Puente’s sequence) [8] under stand-
ard conditions. Positive phage plaques were isolated and subjected to
in vivo excision according to the manufacturer’s protocol.
cDNA clones of mt4-mmp(h) were obtained by screening a human
brain cDNA library (Clontech) using the same probe. But none of
them have enough length to encode a signal peptide.
2.3. 5P RACE method
The RNA-ligase-mediated 5P RACE was performed according to
the method by Chen [15]. Poly(A) RNA (0.2 Wg) extracted from the
human monocytic leukemia cell line THP-1 was transcribed into
cDNA using Superscript II (Gibco BRL) with a gene-speci¢c primer
(5P-GGTTCCTCTTGTTCCACTTGG-3P). A single-stranded oligonu-
cleotide adapter (5P-GTAGGAATTCGGGTTGTAGGGAGGTC-
GACATTGCC-3P) was ligated to the cDNAs using T4 RNA ligase.
The ¢rst round of polymerase chain reaction (PCR) employs the gene-
speci¢c primer [16] and an adapter primer (5P-GGCAATGTC-
GACCTCCCTACAAC-3P), which is complementary to the 3P portion
of the adapter. In the second round, nested PCR is performed with
another gene-speci¢c primer (5P-GGAGCTGTCTAAGGCCATCA-
CA-3P) and an adapter primer (5P-CTCCCTACAACCCGAATTCC-
TAC-3P), which is complementary to the 5P portion of the adapter.
The PCR reactions were performed using Taq DNA polymerase (LA
Taq with GC bu¡er, TaKaRa Co. Ltd.). The PCR products were
cloned into the pGEM-T Easy vector (Promega, Madison, WI, USA).
2.4. Reverse-transcription polymerase chain reaction (RT-PCR)
First-strand cDNA was synthesized from 3 Wg of total RNA using
0.3 Wg of random primers (Gibco BRL, Gaithersburg, MD, USA) and
200 U of Superscript II RNase H3 reverse transcriptase (RTase)
(Gibco BRL, Gaithersburg, MD, USA). After removing random
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primers, 1 Wl of the RT product was used as a template for PCR.
Primer sequences are indicated in the ¢gure legends. To measure the
amount of template, the same PCR products but with an internal
deletion were used as competitors (Fig. 3).
2.5. Immunoblotting
Cells were collected 36 h after transfection, washed three times with
PBS, and lysed in the SDS-PAGE loading bu¡er. Samples were sep-
arated by SDS-PAGE and transferred to a nitrocellulose membrane
(Hybond-ECL, Amersham, Buckinghamshire, UK). After blocking
with 10% fat free dry milk in TBS (20 mM Tris-HCl, pH 7.6,
137 mM NaCl), the membrane was probed with anti-FLAG M2
monoclonal antibodies (Eastman Kodak, New Haven, CT, USA).
The ¢nal concentration of M2 antibody was 5 Wg/ml in 1% BSA/
TBS (with 1 mM CaCl) for 16 h at room temperature. After washing
with TBS, the membrane was incubated with anti-mouse IgG conju-
gated with alkaline phosphatase (Sigma Co. Ltd., St. Louis, MO,
USA) diluted to 1:10 000 in 1% BSA/TBS at room temperature for
1 h.
3. Results
3.1. Analysis of the human mt4-mmp transcript
We adopted the 5P RACE method to analyze the transcripts
for mt4-mmp(h), since we thought there might be a hetero-
geneity in the 5P region of the transcripts and some of them
may contain a coding region for a signal peptide like other
MMP genes. The RNA sample was prepared from the human
monocytic leukemia cell line THP-1 that expresses mt4-
mmp(h) at high levels and the primer for reverse transcription
was designed from the coding sequence for the catalytic do-
main (Fig. 1B). The ampli¢ed 5P RACE products were sub-
cloned into a plasmid vector and nucleotide sequences of
50 isolates were analyzed. Three of them completely matched
Puente’s sequence, however, the other 47 isolates were di¡er-
ent from Puente’s sequence at the 5P region (Fig. 1B). The new
sequence has an open reading frame that starts from the ATG
codon and it is continuous to the reported open reading frame
for MT4-MMP(h) [8]. The predicted N-terminal sequence
contains a hydrophobic stretch that can act as a signal peptide
showing similarity to the other reported MMP genes [17].
Thus, two types of transcripts for human mt4-mmp(h) were
identi¢ed in the THP-1 cells. The minor transcript corre-
sponds to the previously reported sequence (‘Puente-type’)
and the new transcript is the major one that is expected to
encode functional proMT4-MMP (DDBJ/EMBL/GenBank
database: AB021225).
To con¢rm that mRNA species similar to the new mt4-mmp
transcript in human also exist in mouse, mt4-mmp(m) cDNA
was screened from a mouse embryo brain cDNA library. The
mouse cDNA (DDBJ/EMBL/GenBank database: AB021224)
shows more than 90% conservation along with the newly iden-
ti¢ed human sequence (Fig. 1B). At the 5P region, sequence
conservation of the mouse cDNA was only found with the
human major transcript but not with the ‘Puente type’. No
mouse transcripts that correspond to the ‘Puente type’ were
found at least in the 16 cDNA clones analyzed.
3.2. Analysis of the two types of mt4-mmp(h) transcripts
The 5P region (1^137 nt) unique to the ‘Puente-type’ tran-
script contains a repetitive Alu sequence [17] which exists
usually in an intron and spliced out from mature transcripts.
A consensus sequence for the splice acceptor is also found
immediately upstream of 136 nt of the reported sequence
(Fig. 1B). Analysis of the genomic DNA fragment containing
this region revealed that the 5P region of the ‘Puente-type’
transcript (1^136 nt) matched the intron sequence that is con-
tiguous to the second exon of the major transcript (data not
shown).
Expression of the two types of human transcripts was ex-
Fig. 1. Analysis of the 5P region of human and mouse mt4-mmp
cDNAs. A: Schematic illustration of MT-MMPs. The cDNAs for
four human MT-MMPs and their open reading frames (ORFs) in
relation to the domain structures are illustrated. A newly identi¢ed
major transcript for MT4-MMP(h) is also presented at the bottom.
The initiation codon for ‘Puente-type’ MT4-MMP can be seen only
in the propeptide domain. S, signal peptide; P, propeptide domain;
*, furin motif; C, catalytic domain; H, hinge; PEX, hemopexin-like
domain; TM/CP, transmembrane and cytoplasmic domain. Acces-
sion numbers for the genes are also listed. B: Sequence analysis of
the 5P region of human mt4-mmp transcripts by 5P RACE. The mt4-
mmp transcripts in THP-1 cells were analyzed by the 5P RACE
method as described in Section 2. The 5P region of the major tran-
script is aligned with mt4-mmp(m) together with the alignment with
the ‘Puente-type’ mt4-mmp(h) sequence. Translated amino acids are
indicated along with the sequences. Identical nucleotides are indi-
cated by vertical lines. Initiation codons for mt4-mmp(h) and mt4-
mmp(m) are indicated by bold letters. The primer sequence for the
5P RACE is underlined.
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amined by RT-PCR using various human tumor cell lines.
The 5P primer was speci¢c to either one of the transcripts
and the 3P primer was common to both. A set of primers
that ampli¢es the common region of both transcripts was
also used. Transcripts for mt4-mmp(h) were detected in nine
of the 18 tumor cell lines by the common primers and the
major transcript was detected in all of these cell lines (Fig.
2). However, ‘Puente-type’ transcript was detected in four of
the nine cell lines and it was negligible in the other ¢ve cell
lines. It is noteworthy that mt4-mmp is expressed at high levels
in three of the four monocytic leukemia cell lines. A human
breast carcinoma cell line, ZR-75-1, from which cDNA for the
‘Puente-type’ transcript was originally obtained, also ex-
pressed both types of the transcripts.
The amount of the two types of transcripts in breast carci-
noma T-47D cells was measured using speci¢c competitors for
each primer set (Fig. 3). The major transcript was 4.5 pg per
100 ng of total RNA and that of the ‘Puente-type’ transcript
was about 1/12 of the major transcript. Thus, the result is
equivalent to the 5P RACE analysis of THP-1 cells.
3.3. Detection of translation products
To analyze which transcripts direct expression of MT4-
MMP(h), cDNA fragments were subcloned into a mammalian
expression vector and transfected into COS-1 cells. For detec-
tion of the products, they were expressed as fusion proteins
having a FLAG epitope. The FLAG tag was inserted down-
stream of the putative furin motif. Lysates of the cells trans-
fected with the plasmids were analyzed by Western blotting
using a speci¢c anti-FLAG antibody M2 (Fig. 4). The anti-
body detected a 67 kDa product for MT4-MMP(m). For
MT4-MMP(h), 67 and 71 kDa bands were detected only in
the cells that express the major human transcript but not in
those expressing the ‘Puente-type’ transcript. Both transfected
genes were con¢rmed to be transcribed at the same levels
(data not shown). Thus, we concluded that only the major
transcript encodes the gene product (MT4-MMP(h)).
4. Discussion
A new major mt4-mmp(h) transcript was identi¢ed in ad-
Fig. 2. Expression of two types of mt4-mmp(h) transcripts in tumor
cell lines. A: Primers to detect mt4-mmp(h) transcripts, the sizes of
the RT-PCR product and speci¢c competitors are summarized.
Common primers are designed from the common sequences between
two types of the transcripts. The 5P primer for ‘Puente-type’ and
major transcripts was derived from respective 5P unique sequences,
and the 3P primer is common between the two. B: Expression of
two types of transcripts was analyzed by RT-PCR. Total RNA was
extracted from the cells indicated. Cell types are 1, T-cell leukemia;
2, B-cell leukemia; 3, monocytic leukemia; 4, gastric cancer; 5,
breast cancer. RT-PCR products were analyzed by agarose gel elec-
trophoresis.
Fig. 3. Relative ratio of the two types of transcripts. A RNA sam-
ple extracted from T-47D cells was analyzed by competitive PCR.
The RT-PCR reaction was carried out as described in Section 2 ex-
cept that speci¢c competitors (Fig. 2A) were added at the concen-
trations indicated.
Fig. 4. Detection of translation products. Both types of candidates
were expressed in COS-1 cells using a eukaryotic expression vector
pSG5 (Stratagene). For detection, a FLAG epitope was incorpo-
rated into the expected products downstream of the furin motif.
Cells were transiently transfected with the expression plasmids as in-
dicated and lysates were prepared and analyzed by Western blotting
using an anti-FLAG monoclonal antibody M2. FLAG-tagged MT1-
MMP(h) (63 kDa) was used as a positive control.
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dition to the previously reported ‘Puente-type’ transcript. The
‘Puente-type’ transcript could not direct expression of the
gene product but the new transcript expressed 67 and 71
kDa products. Presumably the 71 kDa product corresponds
to proMT4-MMP and the 67 kDa one to the processed ver-
sion at the furin motif. A mouse mt4-mmp cDNA that corre-
sponds to the human new transcript was also obtained and
directed expression of a 67 kDa protein. Thus, functional
cDNAs encoding human and mouse MT4-MMPs were iden-
ti¢ed for the ¢rst time. From the cDNA sequences, human
and mouse MT4-MMP are composed of 605 and 587 amino
acids, respectively.
Both types of transcripts are expressed in several human
tumor cell lines, but the ‘Puente-type’ transcript was detected
only in the cells that express the major transcript. Though the
two types of mt4-mmp(h) transcripts are surely expressed in
the cells, cDNA for the major transcript has not been ob-
tained from the conventional cDNA libraries as Puente de-
scribed [8]. The sequence of the major transcript obtained by
5P RACE revealed that the 5P region unique to the major
transcript is rich in GC content (85%). This would explain
that cDNA clones containing this region could be rare in
the cDNA libraries.
It is not clear how the ‘Puente-type’ transcript is generated.
The most plausible possibility is alternative splicing at the ¢rst
intron, because the ‘Puente type’ retains the ¢rst intron se-
quence at its 5P end. In the previous report by Puente et al. [8],
a weak band of 7.5 kb was detected in addition to the major
2.7 kb band by Northern blotting. This minor transcript may
correspond to the ‘Puente type’. Indeed our preliminary esti-
mation of the ¢rst intron by PCR is about 5 kb.
Mt4-mmp was originally isolated from a human breast car-
cinoma cell line. Both transcripts were detected in three of the
four breast carcinoma cell lines. In contrast, expression of the
gene in gastric carcinoma cell lines was low. High levels of
expression were also found in three of the four monocytic
leukemia cell lines. Expression of MT4-MMP in tumor cells
may contribute to their malignant phenotypes by degrading
the surrounding extracellular matrix or causing processing of
the cell surface molecules.
In conclusion, human and mouse mt4-mmp genes and their
products were identi¢ed. Our results provide a sure basis for
further characterization of MT4-MMP.
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